Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Point of care testing for improving risk- benefit ratio of aspirin and warfarin.
Sheth H, Northwood E, Elliott F, Jackson M, Koref MS, Tyson J, Daly A, O'Halloran J, Sheth J, Sheth F, Parikh K, Bishop DT, Burn J. Sheth H, et al. Among authors: parikh k. Mol Cytogenet. 2014 Jan 21;7(Suppl 1 Proceedings of the International Conference on Human):I54. doi: 10.1186/1755-8166-7-S1-I54. eCollection 2014. Mol Cytogenet. 2014. PMID: 24949102 Free PMC article. No abstract available.
Human enteric glia diversity in health and disease: new avenues for the treatment of Hirschsprung disease.
Windster JD, Kakiailatu NJM, Kuil LE, Antanaviciute A, Sacchetti A, MacKenzie KC, Peulen-Zink J, Kan TW, Bindels E, de Pater E, Doukas M, van den Bosch TPP, Yousefi S, Barakat TS, Meeussen C, Sloots CEJ, Wijnen RMH, Parikh K, Boesmans W, Melotte V, Hofstra RMW, Simmons A, Alves MM. Windster JD, et al. Among authors: parikh k. Gastroenterology. 2024 Dec 24:S0016-5085(24)05803-7. doi: 10.1053/j.gastro.2024.12.011. Online ahead of print. Gastroenterology. 2024. PMID: 39725172
Author's Response to: Comment on "Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM Database" and "Critical Evaluation of Methodological Approaches in ALK TKI Research: Addressing Confounding Factors and Statistical Robustness".
Parikh K. Parikh K. J Thorac Oncol. 2024 Nov;19(11):e66-e67. doi: 10.1016/j.jtho.2024.08.025. J Thorac Oncol. 2024. PMID: 39510710 No abstract available.
551 results